Kathleen Sebelius, a director at Humacyte Inc. ($HUMA), made one open market purchase of company shares worth $66,000 in the last 365 days, with the most recent on April 8, 2025. She reported no open market sales during this period. Her buying activity ranks 2,732nd among nearly 5,000 insiders, compared to an average purchase amount of $1.5 million across 3.3 transactions.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 12, 2025 | Humacyte, Inc. | $HUMA | Sebelius Kathleen | Director | A | Stock Options (right to buy) | 80000 | $0.00 | 80,000.0000 | 155,118,816 | 9999.99% | 0.05% |
| April 8, 2025 | Humacyte, Inc. | $HUMA | Sebelius Kathleen | Director | P | Common Stock | 50000 | $1.32 | 91,207.0000 | 155,118,816 | 121.34% | 0.03% |
| June 13, 2024 | EXACT SCIENCES CORP | $EXAS | Sebelius Kathleen | Not found | A | Common Stock | 7672 | $0.00 | 32,671.0000 | 0 | 30.69% | 0.00% |
| Sept. 10, 2024 | Humacyte, Inc. | $HUMA | Sebelius Kathleen | Director | M | Common Stock | 2479 | $3.35 | 42,755.0000 | 0 | 6.16% | 0.00% |
| Sept. 10, 2024 | Humacyte, Inc. | $HUMA | Sebelius Kathleen | Director | S | Common Stock | 1548 | $5.39 | 41,207.0000 | 0 | 3.62% | 0.00% |
| Sept. 10, 2024 | Humacyte, Inc. | $HUMA | Sebelius Kathleen | Director | M | Stock Options (right to buy) | 4521 | $0.00 | 3,979.0000 | 0 | 53.19% | 0.00% |
| Sept. 10, 2024 | Humacyte, Inc. | $HUMA | Sebelius Kathleen | Director | M | Stock Options (right to buy) | 2479 | $0.00 | 6,021.0000 | 0 | 29.16% | 0.00% |
| Sept. 10, 2024 | Humacyte, Inc. | $HUMA | Sebelius Kathleen | Director | M | Common Stock | 4521 | $4.34 | 43,910.0000 | 0 | 11.48% | 0.00% |
| Sept. 10, 2024 | Humacyte, Inc. | $HUMA | Sebelius Kathleen | Director | S | Common Stock | 3634 | $5.41 | 40,276.0000 | 0 | 8.28% | 0.00% |
| June 13, 2024 | Humacyte, Inc. | $HUMA | Sebelius Kathleen | Director | A | Stock Options (right to buy) | 50000 | $0.00 | 50,000.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2024 | Humacyte, Inc. | $HUMA | Sebelius Kathleen | Director | M | Stock Options (right to buy) | 39389 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| June 14, 2024 | Humacyte, Inc. | $HUMA | Sebelius Kathleen | Director | M | Common Stock | 39389 | $2.56 | 39,389.0000 | 0 | 9999.99% | 0.00% |
| June 13, 2024 | EXACT SCIENCES CORP | $EXAS | Sebelius Kathleen | Not found | A | Common Stock | 6889 | $0.00 | 31,888.0000 | 0 | 27.56% | 0.00% |
| June 15, 2023 | Humacyte, Inc. | $HUMA | Sebelius Kathleen | Director | A | Stock Options (right to buy) | 8500 | $0.00 | 8,500.0000 | 0 | 9999.99% | 0.00% |